Impact of weight loss diet associated with flaxseed on inflammatory markers in men with cardiovascular risk factors: A clinical study

Nutrition Journal

Volumn 14, Issue 1, 2015, Pages

  Cassani, Roberta Soares Lara ^a   Fassini, Priscila Giacomo ^b   Silvah, Jose Henrique ^b   Lima, Cristiane Maria Mártires ^b   Marchini, Júlio Sérgio ^b  

^a Institute of Nutrition   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Flaxseed; Inflammation; Obesity; Weight loss

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; ENTERODIOL; ENTEROLACTONE; GLUCOSE; HERBACEOUS AGENT; INSULIN; ISOPROSTANE DERIVATIVE; LEPTIN; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TUMOR NECROSIS FACTOR ALPHA; URIC ACID; BIOLOGICAL MARKER; CARBOHYDRATE DIET; TRIACYLGLYCEROL;

ADULT; ANTHROPOMETRIC PARAMETERS; ARTICLE; BLOOD PRESSURE MONITORING; BODY MASS; CALORIC INTAKE; CARBOHYDRATE INTAKE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INSULIN BLOOD LEVEL; INTERVENTION STUDY; LINSEED; LIPID BLOOD LEVEL; MALE; METABOLIC PARAMETERS; OBESITY; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; SINGLE BLIND PROCEDURE; WEIGHT REDUCTION; ADMINISTRATION AND DOSAGE; ANTHROPOMETRY; BLOOD; BLOOD PRESSURE; BRAZIL; CARBOHYDRATE DIET; CARDIOVASCULAR DISEASE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET THERAPY; FLAX; INFLAMMATION; LOW CALORY DIET; MIDDLE AGED; PLANT SEED; PROCEDURES; RISK FACTOR;

ADULT; ANTHROPOMETRY; BIOMARKERS; BLOOD PRESSURE; BRAZIL; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; DIET, REDUCING; DIETARY CARBOHYDRATES; FLAX; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; OBESITY; PROSPECTIVE STUDIES; RISK FACTORS; SEEDS; SINGLE-BLIND METHOD; TRIGLYCERIDES; TUMOR NECROSIS FACTOR-ALPHA; WEIGHT LOSS;

EID: 84924164579     PISSN: None     EISSN: 14752891     Source Type: Journal    
DOI: 10.1186/1475-2891-14-5     Document Type: Article

References (42)

1. Hansson GK. Immune mechanisms in atherosclerosis. Arterioscl Throm Vas. 2001;21:1876-90.
2. Couillard C, Ruel G, Archer WR, Pomerleau S, Bergeron J, Couture P, et al. Circulating levels of oxidative stress markers and endothelial adhesion molecules in men with abdominal obesity. J Clin Endocr Metab. 2005;90:6454-9.
3. Paschos G, Zampelas A, Panagiotakos DB, Katsiougiannis S, Griffin B, Votteas V, et al. Effects of flaxseed oil supplementation on plasma adiponectin levels in dyslipidemic men. Eur J Nutr. 2007;46:315-20.
4. Shoelson SE, Lee J, Goldfine AB. Inflammation and insulin resistance. J Clin Invest. 2006;116:1793-801.
5. Fantuzzi G, Mazzone T. Adipose tissue and atherosclerosis. Exploring the connection. Arterioscl Throm Vas. 2007;27:996-1003.
6. Fukumitsu S, Aida K, Ueno N, Ozawa S, Takahashi Y, Kobori M. Flaxseed lignan attenuates high fat diet induced fat accumulation and induces adiponectin expression in mice. Brit J Nutr. 2008;100:669-76.
7. Jensen MD, Ryan DH, Apovian CM, Ard JD, Comuzzie AG, Donato KA, et al. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American college of cardiology/American heart association task force on practice guidelines and the obesity society. Circulation. 2014;129(25 Suppl 2):S102-38.
8. Matarese LE, Pories WJ. Adult weight loss diets: metabolic effects and outcomes. Nutr Clin Pract. 2014;29:759-67.
9. Esmaillzadeh A, Mirmiran P, Azizi F. Whole grain intake and the prevalence of hypertriglyceridemic waist phenotype in tehranian adults. Am J Clin Nutr. 2005;81:55-63.
10. Esmaillzadeh A, Kimiagar M, Mehrabi Y, Azadbakht L, Hu FB, Willett WC. Fruit and vegetable intakes, C-reactive protein, and the metabolic syndrome. Am J Clin Nutr. 2006;84:1489-97.
11. Lemieux I, Pascot A, Prud'homme D, Alméras N, Bogaty P, Nadeau A, et al. Elevated C-reactive protein. Another component of the aterosthrombotic profile of abdominal obesity. Arterioscl Throm Vas. 2001;21:961-7.
12. Krisetherton PM, Harris WS, Appel LJ. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation. 2002;106:2747-57.
13. Bloendon LT, Balikai S, Chittams J, Cunnane SC, Berlin JA, Rader DJ, et al. Flaxseed and cardiovascular risk factors: results from a double blind, randomized, controlled clinical trial. J Am Coll Nutr. 2008;27:65-74.
14. IDF. International Diabetes Federation: The IDF Consensus Worldwide Definition of the Metabolic Syndrome.
15. WHO. Obesity: Presenting and Managing the Goal Epidemic. Report of a WHO Consulation on Obesity. Geneva: World Health Organization; 1998.
16. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA. 2001;285:2486-97.
17. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, et al. Seventh report of the joint national committee on: prevention, detection, evaluation, and treatment of high blood pressure. Hypertension. 2003;42:1206-52.
18. Nicoletti CF, Camelo Jr JS, Dos Santos JE, Marchini JS, Salgado Jr W, Nonino CB. Bioelectrical impedance vector analysis in obese women before and after bariatric surgery: changes in body composition. Nutrition. 2014;30:569-74.
19. NHANES III. National Health and Nutrition Examination Survey. National Center for Health Statistics; 2009. Available: http://www.cdc.gov/nchs/data/nhanes/nhanes-01-02/body-measures-year-3.pdf. Accessed 02 June.
20. Mion Jr D, Gomes MAM, Nobre F, Amodeo C, Kohlmann Jr O, Praxedes JN, et al. IV Brazilian guidelines on hypertension. Arq Bra Cardiol. 2004;82(2):15-22.
21. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499-502.
22. Vasques ACJ. Análise crítica do uso dos índices do homa na avaliação da rersistencia à insulina e capacidade funcional das celulasß panceráticas. Arq Bras Endocrinol. 2008;2:52-61.
23. Hallund J, Tetens I, Bugel S, Tholstrup T, Bruun JM. The effect of a lignan complex isolated from flaxseed on inflammation markers in healthy postmenopausal women. Nutr Metab Cardiovas. 2008;18:497-502.
24. Pan A, Wahnefried WD, Xingwang Y, Yu Z, Li H, Qi Q, et al. Effects of a flaxseed derived lignan supplement on C-reactive protein, IL-6 and retinol binding protein 4 in type 2 diabetic patients. Brit J Nutr. 2008;74:1-5.
25. Prasad K. Hypocholesterolemic and antiatherosclerotic effect of flax lignan complex isolated from flaxseed. Atherosclerosis. 2005;179:269-75.
26. Arts ICW, Hollman PCH. Polyphenols and disease risk in epidemiologic studies. Am J Clin Nutr. 2005;81:317S-25S.
27. Kivelã AM, Kansanen E, Jyrkkânen HK, Nurmi T, Ylãherttuala S, Levonen AL. Enterolactone induces heme oxygenase-1 expression trough nuclear factor E2 related factor 2 activation in endothelial cells. J Nutr. 2008;138:1263-8.
28. Dandona P, Aljada A, Bandyopadhyay A. Inflammation: the link between insulin resistance, obesity and diabetes. Trends Immunol. 2004;25:4-7.
29. Radulian G, Rusu E, Dragomir AD, Posea M. Metabolic effects of low glycaemic index diets. Nutr J. 2009;8:1-8.
30. Madsen EL, Rissanen A, Bruun JM, Skogstrand K, Tonstad S, Hougaard DM, et al. Weight loss larger than 10% is neede for general improvement of levels of circulation adiponectin and markers of inflammation in obese subjects: a 3-year weight loss study. Euro J Endocrinol. 2008;158:179-87.
31. Redman LM, Heilbronn LK, Martin CK, Jonge L, Williamson DA, Delany JP, et al. Metabolic and behavioral compensations in response to caloric restriction: Implications for the maintenance of weight loss. PLoS One. 2009;4:e4377.
32. Guimarães ICB, De Almeida A, Santos AS, Barbosa DBV, Guimarães AC. Pressão arterial: efeito do índice de massa corporal e da circunferência abdominal em adolescentes. Arq Bras Cardiol. 2008;90:426-32.
33. Stevens VJ, Obarzanek E, Cook NR, Lee IM, Appel LJ, Smith West D, et al. Long-term weight loss and changes in blood pressure: results of the trials of hypertension prevention, phase II. Ann Intern Med. 2001;134:1-11.
34. Pan A, Sun J, Chen Y, Ye X, Li H, Yu Z, et al. Effects of a flaxseed-derived lignan supplement in type 2 diabetic patients: a randomized, double-blind, cross-over trial. PLoS One. 2007;2:e1148.
35. Bassett CM, Rodriguez-Leyva D, Pierce GN. Experimental and clinical research findings on the cardiovascular benefits of consuming flaxseed. Appl Physiol Nutr Me. 2009;34:965-74.
36. Prim CR, Baroncini LAV, Précoma LB, Caron PHL, Winter G, Poletti MO, et al. Effects of linseed consumption for a short period of time on lipid profile and atherosclerotic lesions in rabbits fed a hypercholesterolaemic diet. Brit J Nutr. 2012;107:660-4.
37. Harris WS. n-3 fatty acids and serum lipoproteins: human studies. Am J Clin Nutr. 1997;65:1645S-54S.
38. Kontogianni MD, Vlassopoulos A, Gatzieva A, Farmaki AE, Katsiougiannis S, Panagiotakos DB, et al. Flaxseed oil does not affect inflamatory markes and lipid profile compared to olive, in young, healthy, normal weight adults. Metabolism. 2013;62:686-93.
39. Balk EM, Lichtenstein AH, Chung M, Kupelnick B, Chew P, Lau J. Effects of omega-3 fatty acids on serum markers of cardiovascular disease risk: a systematic review. Atherosclerosis. 2006;189:19-30.
40. Jump DB, Depner CM, Tripathy S. Omega-3 fatty acid supplementation and cardiovascular disease. J Lipid Res. 2012;53:2525-45.
41. Santos RD, Gagliardi ACM, Xavier HT, Magnoni CD, Cassani R, Lottenberg AM. Sociedade brasileira de cardiologia. I diretriz sobre o consumo de gorduras e saúde cardiovascular. Arq Bras Cardiol. 2013;100:1-40.
42. Vanharanta M, Voutilainen S, Nurmi T, Kaikkonen J, Roberts LJ, Morrow JD, et al. Association between low serum enterolactone and increased plasma f2-isoprostanes, a measure of lipid peroxidation. Atherosclerosis. 2002;160:465-9.